BRCA1 and BRCA2 mutation spectrum - an update on mutation distribution in a large cancer genetics clinic in Norway.

about

BRCA1 and BRCA2 mutation spectrum - an update on mutation distribution in a large cancer genetics clinic in Norway.

Item

http://www.wikidata.org/entity/Q48534893

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

BRCA1 and BRCA2 mutation spect ...... cer genetics clinic in Norway.

@en

BRCA1 and BRCA2 mutation spect ...... cer genetics clinic in Norway.

@nl

type

Item

label

BRCA1 and BRCA2 mutation spect ...... cer genetics clinic in Norway.

@en

BRCA1 and BRCA2 mutation spect ...... cer genetics clinic in Norway.

@nl

prefLabel

BRCA1 and BRCA2 mutation spect ...... cer genetics clinic in Norway.

@en

BRCA1 and BRCA2 mutation spect ...... cer genetics clinic in Norway.

@nl

P1476

BRCA1 and BRCA2 mutation spect ...... cer genetics clinic in Norway.

@en

P2093

Cecilie Heramb

http://www.w3.org/2001/XMLSchema#string

Eli Marie Grindedal

http://www.w3.org/2001/XMLSchema#string

Ketil Riddervold Heimdal

http://www.w3.org/2001/XMLSchema#string

Lovise Mæhle

http://www.w3.org/2001/XMLSchema#string

Sarah Louise Ariansen

http://www.w3.org/2001/XMLSchema#string

Sheba Lothe

http://www.w3.org/2001/XMLSchema#string

Teresia Wangensteen

http://www.w3.org/2001/XMLSchema#string

P2860

Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies

A global reference for human genetic variation

Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2

Risk reduction and survival benefit of prophylactic surgery in BRCA mutation carriers, a systematic review.

High penetrances of BRCA1 and BRCA2 mutations confirmed in a prospective series.

Current guidelines for BRCA testing of breast cancer patients are insufficient to detect all mutation carriers

Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality.

Prostate cancer in BRCA2 germline mutation carriers is associated with poorer prognosis.

Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.

New recurrent BRCA1/2 mutations in Polish patients with familial breast/ovarian cancer detected by next generation sequencing

P2888

s13053-017-0085-6

P304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S13053-017-0085-6

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-01-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1100279444

http://www.w3.org/2001/XMLSchema#string

P698

29339979

http://www.w3.org/2001/XMLSchema#string

P932

5761139

http://www.w3.org/2001/XMLSchema#string